HBA1 and HBB were the only statistically significant biomarkers with an absolute fold change larger than 0.6 and an FDR-corrected p value smaller than 0.05 in the other biomarker discovery study with bladder cancer patients with a recurrence diagnosis and tumor-free patients in follow up. This evidence concerns the gene HBA1 and urinary bladder cancer.